This book is aimed at anyone who is concerned about the lack of competition in health care markets and the steadily rising cost of health care in the United States. It integrates principles of economics and antitrust policy to explain how monopoly and monopsony contribute to soaring health care costs in the US and explores antitrust remedies.
This book is aimed at anyone who is concerned about the lack of competition in health care markets and the steadily rising cost of health care in the United States. It integrates principles of economics and antitrust policy to explain how monopoly and monopsony contribute to soaring health care costs in the US and explores antitrust remedies.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Roger D. Blair is Professor of Economics at the University of Florida.
Inhaltsangabe
1. Health care markets and competition policy 2. Antitrust policy in the United States Section I. Monopoly: 3 Patents and monopoly pricing of pharmaceuticals 4. Patents and exclusionary product hopping 5. Bundled discounts and peace health Section II. Seller Cartels: 6. Collusion in health care markets 7. Collusion in generic drug markets 8. The hatch-waxman act, patent infringement suits, and reverse payments Appendix The economics of settlements 9. The alleged insulin conspiracy 10. Licensing of health care professionals Section III. Monopsony: 11. Monopsony, dominant buyers, and oligopsony 12. Countervailing power - physician collective bargaining 13. Group purchasing organizations, monopsony, and antitrust policy Section IV. Buyer Cartels: 14. Collusion in the nurse labor market 15. Collusion in the oocyte market 16. No-Poaching agreements and antitrust policy Section V. Mergers and Acquisitions: 17. The economics of horizontal mergers 18. Horizontal merger policy 19. The economic theory of vertical integration 20. Vertical merger policy 21. Concluding remarks.
1. Health care markets and competition policy 2. Antitrust policy in the United States Section I. Monopoly: 3 Patents and monopoly pricing of pharmaceuticals 4. Patents and exclusionary product hopping 5. Bundled discounts and peace health Section II. Seller Cartels: 6. Collusion in health care markets 7. Collusion in generic drug markets 8. The hatch-waxman act, patent infringement suits, and reverse payments Appendix The economics of settlements 9. The alleged insulin conspiracy 10. Licensing of health care professionals Section III. Monopsony: 11. Monopsony, dominant buyers, and oligopsony 12. Countervailing power - physician collective bargaining 13. Group purchasing organizations, monopsony, and antitrust policy Section IV. Buyer Cartels: 14. Collusion in the nurse labor market 15. Collusion in the oocyte market 16. No-Poaching agreements and antitrust policy Section V. Mergers and Acquisitions: 17. The economics of horizontal mergers 18. Horizontal merger policy 19. The economic theory of vertical integration 20. Vertical merger policy 21. Concluding remarks.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826